Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions (Q33175534)

23 July 2017

title

Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions (English)

1 reference

23 July 2017

0 references

1 reference

Bänsch D

1

1 reference

23 July 2017

Brunn J

2

1 reference

23 July 2017

Castrucci M

3

1 reference

23 July 2017

Weber M

4

1 reference

23 July 2017

Gietzen F

5

1 reference

23 July 2017

Borggrefe M

6

1 reference

23 July 2017

Breithardt G

7

1 reference

23 July 2017

Block M

8

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Journal of the American College of Cardiology

23 July 2017

published in

1 reference

23 July 2017

volume

31

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

608-615

1 reference

Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Motor vehicle accidents in patients with an implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

The minimally appropriate electrophysiologic study for the initial assessment of patients with documented sustained monomorphic ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Effects of chronic amiodarone therapy on defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

Effect of Antiarrhythmic Drug Therapy on the Incidence of Shocks in Patients who Receive an Implantable Cardioverter Defibrillator after a Single Episode of Sustained Ventricular Tachycardia/Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900543-3

7 January 2021

10.1016/S0735-1097(97)00543-3

Identifiers

DOI

1 reference

23 July 2017

1 reference